Active, not recruitingPhase 2NCT03604198
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Studying Adrenal Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Corcept Therapeutics
- Principal Investigator
- Ying Ru, MD, PhDCorcept Therapeutics
- Intervention
- relacorilant(drug)
- Enrollment
- 125 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2026
Study locations (30)
- Site 49, Phoenix, Arizona, United States
- Site 35, Stanford, California, United States
- Site 39, Torrance, California, United States
- Site 50, Miami, Florida, United States
- Site 10, Atlanta, Georgia, United States
- Site 9, Chicago, Illinois, United States
- Site 1, Indianapolis, Indiana, United States
- Site 5, Metairie, Louisiana, United States
- Site 27, Baltimore, Maryland, United States
- Site 13, Fall River, Massachusetts, United States
- Site 8, Ann Arbor, Michigan, United States
- Site 36, Rochester, Minnesota, United States
- Site 34, Jackson, Mississippi, United States
- Site 3, St Louis, Missouri, United States
- Site 55, Reno, Nevada, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03604198 on ClinicalTrials.govOther trials for Adrenal Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07168122Establishment and Clinical Application of Reference Intervals of Salivary CortisolShanghai 6th People's Hospital
- RECRUITINGNANCT06250699A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryZhe Meng
- RECRUITINGNANCT05911620Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismCentral Hospital, Nancy, France
- RECRUITINGNANCT05881005NAC- NAFLD and CushingUniversity Hospital, Angers
- RECRUITINGNCT06050057Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyUniversity Hospital Olomouc
- RECRUITINGNCT05521529Cushing's Syndrome Before and After Treatment (CORRECT)University of Aarhus
- ACTIVE NOT RECRUITINGNCT05446779Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden DeathHelsinki University Central Hospital
- RECRUITINGPHASE2NCT03708900Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's SyndromeRECORDATI GROUP